345 related articles for article (PubMed ID: 27289575)
21. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
[TBL] [Abstract][Full Text] [Related]
22. [Predictive value of von Willebrand factor for venous thromboembolism in critically ill patients based on propensity score matching].
Yue J; Wan L; Wang G; Zhang R; Zhang X; Liu O; Yu X; Huang Q; Ren Z
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 Jan; 36(1):73-77. PubMed ID: 38404276
[TBL] [Abstract][Full Text] [Related]
23. Hypertension associated with venous thromboembolism in patients with newly diagnosed lung cancer.
Zhang Y; Yang Y; Chen W; Liang L; Zhai Z; Guo L; Wang C;
Sci Rep; 2016 Jan; 6():19603. PubMed ID: 26797411
[TBL] [Abstract][Full Text] [Related]
24. Novel high-sensitive D-dimer determination predicts chemotherapy-associated venous thromboembolism in intermediate risk lung cancer patients.
Ferroni P; Martini F; Portarena I; Massimiani G; Riondino S; La Farina F; Mariotti S; Guadagni F; Roselli M
Clin Lung Cancer; 2012 Nov; 13(6):482-7. PubMed ID: 22591606
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of risk factors and assessment models for predicting venous thromboembolism in lung cancer patients.
Rupa-Matysek J; Lembicz M; Rogowska EK; Gil L; Komarnicki M; Batura-Gabryel H
Med Oncol; 2018 Apr; 35(5):63. PubMed ID: 29616356
[TBL] [Abstract][Full Text] [Related]
26. Construction of Risk Assessment Model for Venous Thromboembolism After Colorectal Cancer Surgery: A Chinese Single-Center Study.
Yao J; Lang Y; Su H; Dai S; Ying K
Clin Appl Thromb Hemost; 2022; 28():10760296211073748. PubMed ID: 35167387
[TBL] [Abstract][Full Text] [Related]
27. Thyroid-stimulating hormone concentration as an independent risk factor of venous thromboembolism regardless of thyroid function.
Kovářová M; Koller T; Štvrtinová V; Payer J
Endokrynol Pol; 2015; 66(6):474-9. PubMed ID: 26662645
[TBL] [Abstract][Full Text] [Related]
28. Venous thromboembolism and nonsmall cell lung cancer: a pooled analysis of National Cancer Institute of Canada Clinical Trials Group trials.
Hicks LK; Cheung MC; Ding K; Hasan B; Seymour L; Le Maître A; Leighl NB; Shepherd FA
Cancer; 2009 Dec; 115(23):5516-25. PubMed ID: 19711465
[TBL] [Abstract][Full Text] [Related]
29. Risk factors associated with venous thromboembolism in tuberculosis: A case control study.
Nan GY; Fei H; Zhen W; Yun DT
Clin Respir J; 2022 Dec; 16(12):835-841. PubMed ID: 36344481
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of the neutrophil-lymphocyte ratio in venous thromboembolism patients with lung cancer.
Go SI; Lee A; Lee US; Choi HJ; Kang MH; Kang JH; Jeon KN; Park MJ; Kim SH; Lee GW
Lung Cancer; 2014 Apr; 84(1):79-85. PubMed ID: 24524817
[TBL] [Abstract][Full Text] [Related]
31. Tissue Factor Pathway Inhibitor 2: A Novel Biomarker for Predicting Asymptomatic Venous Thromboembolism in Patients with Epithelial Ovarian Cancer.
Yamanaka S; Miyake R; Yamada Y; Kawaguchi R; Ootake N; Myoba S; Kobayashi H
Gynecol Obstet Invest; 2022; 87(2):133-140. PubMed ID: 35613543
[TBL] [Abstract][Full Text] [Related]
32. A modified Khorana score as a risk assessment tool for predicting venous thromboembolism in newly diagnosed advanced lung cancer.
Li S; Gao P; Qiu J; He X; Mao Y
J Thromb Thrombolysis; 2021 Oct; 52(3):898-903. PubMed ID: 33599857
[TBL] [Abstract][Full Text] [Related]
33. Clinical conditions and patient factors significantly influence diagnostic utility of D-dimer in venous thromboembolism.
Qasim A; Duggan M; O'Connell N; O'Driscoll A
Blood Coagul Fibrinolysis; 2009 Jun; 20(4):244-7. PubMed ID: 19276796
[TBL] [Abstract][Full Text] [Related]
34. Haematological variables and risk of future venous thromboembolism in the British Regional Heart Study on men. Combined D-dimer and APTT as a predictive test for thromboembolism?
Wannamethee SG; Papacosta O; Lennon L; Whincup PH; Rumley A; Lowe GDO
Br J Haematol; 2022 Aug; 198(3):587-594. PubMed ID: 35655415
[TBL] [Abstract][Full Text] [Related]
35. Can an age-adjusted D-dimer level be adopted in managing venous thromboembolism in the emergency department? A retrospective cohort study.
Jaconelli T; Eragat M; Crane S
Eur J Emerg Med; 2018 Aug; 25(4):288-294. PubMed ID: 28079562
[TBL] [Abstract][Full Text] [Related]
36. Biomarkers for the diagnosis of venous thromboembolism: D-dimer, thrombin generation, procoagulant phospholipid and soluble P-selectin.
Riva N; Vella K; Hickey K; Bertù L; Zammit D; Spiteri S; Kitchen S; Makris M; Ageno W; Gatt A
J Clin Pathol; 2018 Nov; 71(11):1015-1022. PubMed ID: 30093507
[TBL] [Abstract][Full Text] [Related]
37. Epidemiology and risk factors for venous thromboembolism in lung cancer.
Ay C; Ünal UK
Curr Opin Oncol; 2016 Mar; 28(2):145-9. PubMed ID: 26730487
[TBL] [Abstract][Full Text] [Related]
38. The Diagnostic Value of the Systemic Immune-Inflammation Index for Venous Thromboembolism in Lung Cancer Patients: A Retrospective Study.
Zhang L; Liu X; Yang R; Yang Y; Chen X
Mediators Inflamm; 2022; 2022():9215311. PubMed ID: 36046761
[TBL] [Abstract][Full Text] [Related]
39. [Clinical characteristic and outcomes of lung cancer patients with venous thromboembolism].
Xu X; Yang H; Qiao L; Tan Z; Jin J; Jin Y; Fang B; Sun T; Wang C
Zhonghua Yi Xue Za Zhi; 2014 Jul; 94(26):2045-9. PubMed ID: 25312667
[TBL] [Abstract][Full Text] [Related]
40. The prognostic value of D-dimer in lung cancer.
İnal T; Anar C; Polat G; Ünsal İ; Halilçolar H
Clin Respir J; 2015 Jul; 9(3):305-13. PubMed ID: 24720709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
